학술논문
Incidence and Risk Factors for Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients with Systemic Autoimmune Rheumatic Diseases
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
23265205